Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10
Closed 4019
2023
Q2
$0 Hold
10
﹤0.01% 3844
2023
Q1
$0 Buy
+10
New +$257 ﹤0.01% 4220
2022
Q4
Sell
-7
Closed -$237 4739
2022
Q3
$0 Sell
7
-3
-30% -$413 ﹤0.01% 5170
2022
Q2
$1K Hold
10
﹤0.01% 4609
2022
Q1
$2K Buy
10
+4
+67% +$837 ﹤0.01% 4679
2021
Q4
$1K Sell
6
-12
-67% -$4.58K ﹤0.01% 5023
2021
Q3
$9K Buy
18
+12
+200% +$7.47K ﹤0.01% 4012
2021
Q2
$4K Hold
6
﹤0.01% 4591
2021
Q1
$4K Sell
6
-2
-25% -$1.74K ﹤0.01% 4513
2020
Q4
$4K Buy
8
+3
+60% +$2.44K ﹤0.01% 3786
2020
Q3
$5K Buy
+5
New +$7.25K ﹤0.01% 3498

Other funds holding IBIO

Cutler Group's IBIO Position: Q3 2023 in Review

Cutler Group sold out of iBio (IBIO) in Q3 2023, closing a stake of 10 shares.

Cutler Group first reported a position in IBIO in Q3 2020 and held it in 11 quarters. The position peaked at $9K in Q3 2021. 26 funds tracked by Wall St. Rank hold IBIO as of Q3 2023.

  • Cutler Group reported no remaining iBio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 10 iBio shares in Q3 2023.
  • Cutler Group first reported a position in iBio in Q3 2020 and held it in 11 quarters.
  • Cutler Group's iBio position peaked at $9K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held iBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.